US Stock MarketDetailed Quotes

APVO Aptevo Therapeutics

Watchlist
  • 4.090
  • -1.540-27.35%
Close Dec 13 16:00 ET
  • 4.130
  • +0.040+0.98%
Post 20:01 ET
2.05MMarket Cap-0.01P/E (TTM)

Aptevo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
16.31%-5.22M
-28.11%-6.15M
-245.66%-6.65M
44.20%-11.73M
11.55%-5.25M
9.51%-6.24M
-56.45%-4.8M
189.23%4.57M
3.03%-21.02M
-53.07%-5.94M
Net income from continuing operations
19.45%-5.1M
25.98%-5.88M
-346.45%-6.83M
-316.91%-17.41M
-27.17%-5.9M
17.15%-6.33M
-128.38%-7.95M
136.03%2.77M
128.21%8.03M
25.99%-4.64M
Operating gains losses
----
----
----
----
----
----
----
----
1,075.00%47K
----
Depreciation and amortization
-31.71%84K
-39.33%91K
-40.45%106K
-37.07%567K
-27.95%116K
-44.59%123K
-45.65%150K
-26.45%178K
-21.24%901K
-37.11%161K
Other non cash items
----
----
----
100.03%10K
--0
--0
--0
-99.41%10K
-611.04%-33.94M
-101.02%-23K
Change In working capital
27.01%-354K
-125.06%-634K
-193.04%-642K
35.77%2.91M
109.57%176K
-348.72%-485K
-32.32%2.53M
1,280.00%690K
180.75%2.14M
-510.96%-1.84M
-Change in receivables
--0
--0
--0
114.78%2.5M
--0
--0
--0
354.55%2.5M
189.88%1.16M
-340.14%-2.5M
-Change in prepaid assets
-118.13%-746K
-78.95%312K
140.19%338K
-56.90%153K
46.91%-146K
44.66%-342K
55.67%1.48M
-384.12%-841K
-18.58%355K
-157.89%-275K
-Change in payables and accrued expense
710.53%464K
-178.90%-879K
-1.87%-926K
231.47%518K
-60.67%389K
-108.82%-76K
176.99%1.11M
-13.91%-909K
79.43%-394K
549.55%989K
-Change in other current assets
17.92%125K
18.63%121K
11.65%115K
-35.38%422K
5.71%111K
1.92%106K
-38.55%102K
-62.95%103K
-42.62%653K
-62.63%105K
-Change in other current liabilities
-13.87%-197K
-11.90%-188K
-3.68%-169K
-286.34%-682K
-12.66%-178K
-13.07%-173K
-117.63%-168K
40.94%-163K
135.92%366K
41.26%-158K
Cash from discontinued investing activities
Operating cash flow
16.31%-5.22M
-28.11%-6.15M
-245.66%-6.65M
44.20%-11.73M
11.55%-5.25M
9.51%-6.24M
-56.45%-4.8M
189.23%4.57M
3.03%-21.02M
-53.07%-5.94M
Investing cash flow
Cash flow from continuing investing activities
0
95.93%-29K
0
Net PPE purchase and sale
----
----
----
--0
----
----
----
----
95.93%-29K
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
--0
--0
--0
95.93%-29K
--0
Financing cash flow
Cash flow from continuing financing activities
13.01%4.91M
725.16%3.97M
99.84%-3K
329.28%6M
-49.22%3.05M
968.80%4.34M
115.14%481K
62.05%-1.87M
-110.00%-2.62M
294.99%6M
Net issuance payments of debt
--0
--0
--0
71.74%-3.47M
--0
--0
--0
67.80%-3.47M
-16.27%-12.27M
---500K
Net common stock issuance
13.01%4.91M
725.36%3.97M
--0
-7.30%6.43M
-99.98%1K
--4.34M
10.32%481K
--1.6M
-32.24%6.93M
--6.5M
Proceeds from stock option exercised by employees
----
----
----
--3.05M
----
----
----
----
--0
--0
Net other financing activities
--0
---1K
62.50%-3K
-100.37%-10K
---2K
--0
--0
-100.14%-8K
-89.25%2.72M
--0
Cash from discontinued financing activities
Financing cash flow
13.01%4.91M
725.16%3.97M
99.84%-3K
329.28%6M
-49.22%3.05M
968.80%4.34M
115.14%481K
62.05%-1.87M
-110.00%-2.62M
294.99%6M
Net cash flow
Beginning cash position
-61.60%8.07M
-59.53%10.25M
-25.32%16.9M
-51.11%22.64M
-15.36%19.11M
-29.93%21.01M
-30.13%25.33M
-51.12%22.64M
8.86%46.3M
-57.70%22.58M
Current changes in cash
83.49%-313K
49.47%-2.18M
-347.09%-6.65M
75.78%-5.73M
-3,840.68%-2.21M
74.38%-1.9M
31.10%-4.32M
126.79%2.69M
-727.94%-23.67M
100.83%59K
End cash Position
-59.43%7.75M
-61.60%8.07M
-59.53%10.25M
-25.32%16.9M
-25.32%16.9M
-15.36%19.11M
-29.93%21.01M
-30.13%25.33M
-51.11%22.64M
-51.11%22.64M
Free cash flow
16.31%-5.22M
-28.11%-6.15M
-245.66%-6.65M
44.28%-11.73M
11.55%-5.25M
9.57%-6.24M
-55.19%-4.8M
189.23%4.57M
5.99%-21.05M
-48.55%-5.94M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 16.31%-5.22M-28.11%-6.15M-245.66%-6.65M44.20%-11.73M11.55%-5.25M9.51%-6.24M-56.45%-4.8M189.23%4.57M3.03%-21.02M-53.07%-5.94M
Net income from continuing operations 19.45%-5.1M25.98%-5.88M-346.45%-6.83M-316.91%-17.41M-27.17%-5.9M17.15%-6.33M-128.38%-7.95M136.03%2.77M128.21%8.03M25.99%-4.64M
Operating gains losses --------------------------------1,075.00%47K----
Depreciation and amortization -31.71%84K-39.33%91K-40.45%106K-37.07%567K-27.95%116K-44.59%123K-45.65%150K-26.45%178K-21.24%901K-37.11%161K
Other non cash items ------------100.03%10K--0--0--0-99.41%10K-611.04%-33.94M-101.02%-23K
Change In working capital 27.01%-354K-125.06%-634K-193.04%-642K35.77%2.91M109.57%176K-348.72%-485K-32.32%2.53M1,280.00%690K180.75%2.14M-510.96%-1.84M
-Change in receivables --0--0--0114.78%2.5M--0--0--0354.55%2.5M189.88%1.16M-340.14%-2.5M
-Change in prepaid assets -118.13%-746K-78.95%312K140.19%338K-56.90%153K46.91%-146K44.66%-342K55.67%1.48M-384.12%-841K-18.58%355K-157.89%-275K
-Change in payables and accrued expense 710.53%464K-178.90%-879K-1.87%-926K231.47%518K-60.67%389K-108.82%-76K176.99%1.11M-13.91%-909K79.43%-394K549.55%989K
-Change in other current assets 17.92%125K18.63%121K11.65%115K-35.38%422K5.71%111K1.92%106K-38.55%102K-62.95%103K-42.62%653K-62.63%105K
-Change in other current liabilities -13.87%-197K-11.90%-188K-3.68%-169K-286.34%-682K-12.66%-178K-13.07%-173K-117.63%-168K40.94%-163K135.92%366K41.26%-158K
Cash from discontinued investing activities
Operating cash flow 16.31%-5.22M-28.11%-6.15M-245.66%-6.65M44.20%-11.73M11.55%-5.25M9.51%-6.24M-56.45%-4.8M189.23%4.57M3.03%-21.02M-53.07%-5.94M
Investing cash flow
Cash flow from continuing investing activities 095.93%-29K0
Net PPE purchase and sale --------------0----------------95.93%-29K--0
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0--0--0--095.93%-29K--0
Financing cash flow
Cash flow from continuing financing activities 13.01%4.91M725.16%3.97M99.84%-3K329.28%6M-49.22%3.05M968.80%4.34M115.14%481K62.05%-1.87M-110.00%-2.62M294.99%6M
Net issuance payments of debt --0--0--071.74%-3.47M--0--0--067.80%-3.47M-16.27%-12.27M---500K
Net common stock issuance 13.01%4.91M725.36%3.97M--0-7.30%6.43M-99.98%1K--4.34M10.32%481K--1.6M-32.24%6.93M--6.5M
Proceeds from stock option exercised by employees --------------3.05M------------------0--0
Net other financing activities --0---1K62.50%-3K-100.37%-10K---2K--0--0-100.14%-8K-89.25%2.72M--0
Cash from discontinued financing activities
Financing cash flow 13.01%4.91M725.16%3.97M99.84%-3K329.28%6M-49.22%3.05M968.80%4.34M115.14%481K62.05%-1.87M-110.00%-2.62M294.99%6M
Net cash flow
Beginning cash position -61.60%8.07M-59.53%10.25M-25.32%16.9M-51.11%22.64M-15.36%19.11M-29.93%21.01M-30.13%25.33M-51.12%22.64M8.86%46.3M-57.70%22.58M
Current changes in cash 83.49%-313K49.47%-2.18M-347.09%-6.65M75.78%-5.73M-3,840.68%-2.21M74.38%-1.9M31.10%-4.32M126.79%2.69M-727.94%-23.67M100.83%59K
End cash Position -59.43%7.75M-61.60%8.07M-59.53%10.25M-25.32%16.9M-25.32%16.9M-15.36%19.11M-29.93%21.01M-30.13%25.33M-51.11%22.64M-51.11%22.64M
Free cash flow 16.31%-5.22M-28.11%-6.15M-245.66%-6.65M44.28%-11.73M11.55%-5.25M9.57%-6.24M-55.19%-4.8M189.23%4.57M5.99%-21.05M-48.55%-5.94M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data